Antinociceptive and antiamnesic properties of the presynaptic cholinergic amplifier PG-9

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 3, 1998, Pages 806-816

  Ghelardini, Carla ^a   Galeotti, Nicoletta ^a   Gualtieri, Fulvio ^a   Marchese, Vittorio ^a   Bellucci, Cristina ^a   Bartolini, Alessandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 (4 BROMOPHENYL)PROPIONIC ACID 3ALPHA TROPYL ESTER; 3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 2 (DIETHYLAMINO)ETHYL ESTER; ACETYLCHOLINE; ALPHA METHYLHISTAMINE; ANTINOCICEPTIVE AGENT; ATROPINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; DICYCLOVERINE; HEMICHOLINIUM 3; MUSCARINIC M1 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR; NALOXONE; PIRENZEPINE; QUINPIROLE; RESERPINE; SCOPOLAMINE; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; GUINEA PIG; HEART ATRIUM; HOT PLATE TEST; ILEUM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PASSIVE AVOIDANCE; PAW EDEMA; PRIORITY JOURNAL; RABBIT; RAT; RECEPTOR AFFINITY; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST; UTERUS; VAS DEFERENS;

AMNESIA; ANALGESICS, NON-NARCOTIC; ANIMALS; AVOIDANCE LEARNING; CHOLINERGIC AGENTS; GUINEA PIGS; MALE; MICE; MOTOR ACTIVITY; PHENYLPROPIONATES; RABBITS; RATS; RATS, INBRED F344; RATS, WISTAR; STEREOISOMERISM; TROPANES;

EID: 0031888642     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Bartolini A, Galli A, Ghelardini C, Giotti A, Malcangio M, Malmberg-Aiello P and Zucchi PL (1987) Antinociception induced by systemic administration of local anaesthetics depends on a cholinergic mechanism. Br J Pharmacol 92:711-721.
2. Bartolini A, Ghelardini C, Fantetti L, Malcangio M, Malmberg-Aiello P and Giotti A (1992) Role of muscarinic receptor subtypes in central antinociception. Br J Pharmacol 105:77-82.
3. 3 agonist decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs. Br J Pharmacol 101:448-452.
4. 3 receptor subtypes. Br J Pharmacol 107:919-923.
5. Consola S, Arnaboldi S, Giorgi S, Russi G and Ladinsky H (1994) 5-HT4 receptor stimulation facilitates acetylcholine release in frontal cortex. NeuroReport 5:1230-1232.
6. Coyle MJ (1995) A cholinergic hypothesis for Alzheimer's disease, in Learning and Memory Molecular Bases (Meyer L and Nordeberg GH, eds) pp 11-32, Pergamon Press, London, UK.
7. D'Amour FE and Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74-79.
8. Dei S, Bellucci C, Gualtieri F, Romanelli MN, Scapecchi S, Teodori E, Bartolini A and Ghelardini C (1995) Analgesic, antimuscarinic activity and enantioselectivity of the four isomers of 3-quinuclidinyl tropate as compared with th enantiomers of hyoscyamine. Farmaco 50:303-309.
9. Dörje F, Friebe T, Tacke R, Mutschler E and Lambrecht G (1990) Novel pharmacological profile of muscarinic receptors mediating contraction of the guinea-pig uterus. Naunyn-Schmiedebergs Arch Pharmacol 342: 284-289.
10. Ellman GL, Courtney KD, Andres VJR and Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95.
11. 2 receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens. Eur J Pharmacol 151:205-221.
12. Eltze M and Figala V (1988) Affinity and selectivity of biperiden enantiomers for muscarinic receptor subtypes. Eur J Pharmacol 158:11-19.
13. Eltze M, Gonne S, Riedel R, Schlotke B, Schudt C and Simon WA (1985) Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug. Eur J Pharmacol 112:211-224.
14. Ferguson-Anderson W (1952) Action of belladonna on gastric motility in man. Lancet ii:255-258.
15. Galeotti N, Ghelardini C and Bartolini A (1995) Involvement of the serotoninergic system in the analgesic effect of tricyclic antidepressants. Behav Pharmacol 6:Suppl 1, 20-21.
16. George R, Haslett WL and Jendel DJ (1962) The central action of a metabolite of tremorine. Life Sci 1:361-363.
17. Ghelardini C, Malmberg-Aiello P, Giotti A, Malcangio M and Bartolini A (1990) Investigation into atropine-induced antinociception. Br J Pharmacol 101:49-54.
18. Ghelardini C, Giotti A, Gualtieri F, Matucci R, Romanelli MN, Scapecchi S, Teodori E and Bartolini A (1992) Presynaptic auto- and hetero-receptors in the cholinergic regulation of pain, in Trends in Receptor Research (Angeli P, Gulini U and Quaglia W, eds) pp 95-114, Elsevier Science Publisher B. V., Amsterdam, the Netherlands.
19. Ghelardini C, Gualtieri F, Baldini M, Dei S, Romanelli MN, Giotti A and Bartolini A (1993) R-(+)-hyoscyamine: the first and selective antagonist for guinea-pig uterus muscarinic receptor subtypes. Life Sci 52:569.
20. 1A agonist 8-OH-DPAT induces antinociception through a cholinergic mechanism. Can J Physiol Pharmacol Suppl. IUPHAR; P. 13.9.43, p 380.
21. 4 agonists: BIMU 1 and BIMU 8. Life Sci 58:2297-2309.
22. Ghelardini C, Gualtieri F, Romanelli MN, Angeli P, Pepeu G, Giovannini MG, Casamenti F, Malmberg-Aiello P, Giotti A and Bartolini A (1997) Stereoselective increase in cholinergic transmission by R-(+)-hyoscyamine. Neuropharmacology 36:281-294.
23. Gorell JM and Czarnecki B (1986) Pharmacological evidence for direct dopaminergic regulation of striatal acetylcholine release. Life Sci 38:2239-2246.
24. Gualtieri F, Romanelli MN, Scapecchi S, Teodori E, Bartolini A, Fantetti L, Ghelardini C and Giotti A (1991) Muscarinic presynaptic autoreceptors and muscarinic postsynaptic receptors have opposite stereochemical requirements. Med Chem Res 1:52-58.
25. Gualtieri F, Conti G, Dei S, Giovannoni P, Nannucci F, Romanelli MN, Scapecchi S, Teodori E, Fanfani L, Ghelardini C, Bartolini A and Giotti A (1994) Presynaptic cholinergic modulators as potent nootropic and analgesic drugs. I. Tropic and 2-phenylpropionic acid esters. J Med Chem 37:1704-1711.
26. Haley TJ and McCormick WG (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 12:12-15.
27. Harris LS, Dewey WL, Howes J, Kennedy JS and Pars H (1969) Narcotic antagonists analgesics: interaction with cholinergic system. J Pharmacol Exp Ther 169:17-22.
28. Hendershot LC and Forsaith J (1959) Antagonism of the frequency of phenylqunone-induced writhing in the mouse by weak analgesics and nonanalgesics. J Pharmacol Exp Ther 125:237-240.
29. Herz A (1962) Wirkungen des Arecolins auf das Zentralnervensystem. Arch Exp Pathol Pharmakol 242:414-429.
30. Hood DD, Eisenach JC and Tuttle R (1995) Phase I safety assessment of intrathecal neostigmine methylsulphate in humans. Anesthesiology 82:331-343.
31. 1 receptors. J Pharmacol Exp Ther 266:557-562.
32. Jarvik ME and Kopp R (1967) An improved one-trial passive avoidance learning situation. Psychol Rep 21:221-224.
33. Koster R, Anderson M and De Beer EJ (1959) Acetic acid for analgesic screening. Fed Proc 18:412.
34. 3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from brain slices. Brain Res 496:285-294.
35. Leiber D, Harbon S, Guillet J-G, Andr 138 C and Strosberg D (1984) Monoclonal antibodies to purified muscarinic receptor display agonist-like activity. Proc Natl Acad Sci USA 81:4331-4334.
36. Leighton GE, Rodriguez RE, Hill RG and Hughes J (1988) k-opioid agonists produce antinociception after i. v. and i. c. v. but not intrathecal administration in the rat. Br J Pharmacol 93:553-560.
37. B antagonist, prevents antinociception and muscle-relaxant effect induced by baclofen. Br J Pharmacol 103:1303-1308.
38. Malmberg-Aiello P, Lamberti C, Ghelardini C, Giotti A and Bartolini A (1994) Role of histamine in rodent antinociception. Br J Pharmacol 111:1269-1279.
39. Marc S, Leiber D and Harbon S (1986) Carbachol and oxytocin stimulate the generation of inositol phosphates in the guinea-pig myometrium. FEBS Lett 201: 9-14.
40. 4 muscarinic receptor subtypes mediating cyclic AMP inhibition. Mol Pharmacol 40:1014-1022.
41. McKinney M, Miller JH and Aagaard PJ (1993) Pharmacological characterization of the rat hippocampal muscarinic autoreceptor. J Pharmacol Exp Ther 264:74-78.
42. O'Callaghan JP and Holtzman SG (1975) Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure. J Pharmacol Exp Ther 192:497-505.
43. Pedigo NW, Dewey WL and Harris LS (1975) Determination and characterization of the antinociceptive activity of intracerebroventricularly administered acetylcholine. J Pharmacol Exp Ther 193:845-852.
44. 4 agonist endowed with potent antinociceptive activity. Arzneim Forsch/Drug Res 43:(II)913-918.
45. Romanelli MN, Bartolini A, Bertucci C, Dei S, Ghelardini C, Giovannini MG, Gualtieri F, Pepeu G, Scapecchi S and Teodori E (1995) Synthesis, absolute configuration and cognition enhancing activity of SM-21, SM-32 and PG-9, new central ACh releasers. Proceedings of II International Symposium "Medicinal Chemistry Approaches to Alzheimer Disease," Strasbourg, August 28-30, 1995.
46. 1 dopamine receptors in dopaminergic control of striatal cholinergic transmission. Life Sci 31:2883-2890.
47. Stillman MJ, Shukitt-Hale B, Kong RM, Levy A and Lieberman HR (1993) Elevation of hippocampal extracellular acetylcholine levels by methoctramine. Brain Res Bull 32:385-389.
48. Töröcsik A and Vizi ES (1991) Presynaptic effects of methoctramine on release of acetylcholine. Neuropharmacology 30:293-298.
49. Vaught J, Pelley K, Costa LG, Sether P and Enna SJ (1985) A comparison of the antinociceptive responses to GABA-receptor agonists THIP and baclofen. Neuropharmacology 24:211-216.
50. 2, M3 and putative M4 muscarinic receptor subtypes. Br J Pharmacol 105:97-102.
51. 2-receptors. Naunyn-Schmiedebergs Arch Pharmacol 338:250-255.